23
Jun 2026
Longer breastfeeding links to fewer ADHD symptoms in children
Longer durations of full breastfeeding are linked to fewer ADHD symptoms in children, suggesting early feeding patterns may influence neurodevelopment.
Stay Informed!
23
Jun 2026
Elite athletes with higher vitamin D show healthier lipid profiles
Higher serum 25-hydroxyvitamin D levels were independently associated with lower LDL-C, triglycerides, and lipoprotein(a) in 773 male professional athletes. The cross-sectional study cannot establish causality, but it suggests that vitamin D status may be linked to cardiovascular risk-related lipid markers, even in elite athletic populations.
23
Jun 2026
Trial identifies 4 grams a day as the tested safe level for L-tyrosine in healthy men
A randomized, crossover trial in healthy adult men found that 4 weeks of L-tyrosine supplementation at doses up to 4 g/day did not cause clinically meaningful changes in safety markers, diet, blood pressure, or body measures. The highest tested dose, 4 g/day, was identified as the no-observed-adverse-effect level under the study’s four-week conditions, although broader and longer-term studies are still needed.
23
Jun 2026
50-year review shows global Ebola spread remains rare despite outbreak fears
Researchers reviewed Ebola disease cases outside Africa from 1976 to May 2026 and found only 28 confirmed epidemic-linked cases, most involving medical evacuation or occupational exposure. Only four latent travelers were diagnosed after border screening, suggesting that undetected intercontinental spread remains rare when outbreaks are controlled at source.
23
Jun 2026
Andes virus cases on MV Hondius highlight hidden risks of confined travel
A Eurosurveillance report describes a multi-country response to an Andes virus outbreak linked to the Dutch-flagged expedition cruise ship MV Hondius, with 13 cases and three deaths reported as of June 18, 2026. Investigators found evidence consistent with an initial zoonotic infection before embarkation, followed by likely person-to-person transmission among passengers and crew in a confined ship setting.
22
Jun 2026
Insilico and SK Biopharmaceuticals partner to develop AI-driven neuroimmune therapies
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceuticals, a Korean-based company leads the way in biotech innovation with groundbreaking drug research, development, and commercialization worldwide, announced a research and development collaboration at the BIO 2026 International Convention to discover AI-enabled innovative drug candidates in the neuroimmune area of the central nervous system.
22
Jun 2026
Accelerated biological aging may drive rising early-onset cancer risk
Cancer is often considered a disease of aging. Older adults are at higher risk because they have had more time to accumulate cellular damage that can trigger tumor formation.
22
Jun 2026
New AI platform tracks cancer treatment responses in tumor organoids
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new platform that combines 3D bioprinting, advanced imaging and artificial intelligence to better monitor how cancer responds to treatment.
22
Jun 2026
Hyperemesis gravidarum increases risks for pregnancy and birth complications
Pregnant women with a severe form of nausea face increased risks for several pregnancy and birth complications, according to a new Stanford Medicine study of 2.5 million California births.
22
Jun 2026
Novel IL1RAP therapy advances toward pancreatic cancer clinical trial
Blocking IL1RAP, a receptor that sits at a key control point in inflammatory signaling, can disrupt the tumor-driven inflammatory network that helps pancreatic cancer resist treatment, according to new research.
